Newly diagnosed diabetes vs. pre-existing diabetes upon admission for COVID-19: Associated factors, short-term outcomes, and long-term glycemic phenotypes

Newly diagnosed diabetes vs. pre-existing diabetes upon admission for COVID-19: Associated factors, short-term outcomes, and long-term glycemic phenotypes

Aims: High rates of newly diagnosed diabetes mellitus (NDDM) have been reported in association with coronavirus disease-2019 (COVID-19). Factors associated with NDDM and long-term glycemic outcomes are not known. Methods: Retrospective review of individuals admitted with COVID-19 and diabetes mellit...

Full description

Bibliographic Details
Main Authors: Colling, C. (Author), Cromer, S.J (Author), Leary, M. (Author), Putman, M.S (Author), Schatoff, D. (Author), Selen, D.J (Author), Stamou, M.I (Author), Wexler, D.J (Author)
Format: Article
Language:English
Published: Elsevier Inc. 2022
Subjects:
adult
age
aged
antidiabetic agent
Article
Blood Glucose
Caucasian
clinical outcome
complication
controlled study
coronavirus disease 2019
COVID-19
diabetes mellitus
Diabetes Mellitus
dipeptidyl peptidase IV inhibitor
female
follow up
glucagon like peptide 1 receptor agonist
glucose
glucose blood level
hospital admission
human
Humans
hyperglycemia
Hyperglycemia
impaired glucose tolerance
insulin
insulin treatment
intensive care unit
length of stay
major clinical study
male
medicaid
medicare
metformin
Newly diagnosed diabetes
phenotype
Phenotype
race difference
Retrospective Studies
retrospective study
risk factor
semaglutide
Stress hyperglycemia
sulfonylurea
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items